Neuroone Medical Technologies (NMTC) Invested Capital (2016 - 2024)

Neuroone Medical Technologies (NMTC) posted Invested Capital of $121896.0 for Q1 2024, down 5.59% on a QoQ basis from $129116.0 in Q3 2023.

Neuroone Medical Technologies (NMTC) Invested Capital (2016 - 2024) Analysis & Trends

Neuroone Medical Technologies' Invested Capital history runs 6 years deep, the most recent figure standing at $121896.0 for Q1 2024.

Quarterly Invested Capital changed N/A year-over-year to $121896.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $121896.0 (down 5.59% YoY) and the FY2023 annual result came in at $129116.0, changed N/A from the prior year.
Invested Capital was $121896.0 for Q1 2024 at Neuroone Medical Technologies, down from $129116.0 in the prior quarter.
Across five years, Invested Capital topped out at $129116.0 in Q3 2023 and bottomed at $121896.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	4.41 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	499.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	41.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	1.41 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	7.00 Mn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	15.00 Mn
10	Neuroone Medical Technologies	7.99 Mn	5.19 Mn	990,264.00	-

Download Data